Education
About Us
Working with TipRanks
Follow Us
Eli Lilly & Co (GB:0Q1G)
LSE:0Q1G
Total Valuation
Eli Lilly & Co has a market cap or net worth of $566.38B. The enterprise value is CHF761.80B.
Market Cap$566.38B
Enterprise ValueCHF761.80B
Share Statistics
Eli Lilly & Co has 947,989,140 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding947,989,140
Owned by Insiders10.30%
Owned by Institutions10.86%
Financial Efficiency
Eli Lilly & Co’s return on equity (ROE) is 0.74 and return on invested capital (ROIC) is 51.01%.
Return on Equity (ROE)0.74
Return on Assets (ROA)0.13
Return on Invested Capital (ROIC)51.01%
Return on Capital Employed (ROCE)0.26
Revenue Per Employee958.36K
Profits Per Employee225.32K
Employee Count47,000
Asset Turnover0.57
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Eli Lilly & Co is 65.43. Eli Lilly & Co’s PEG ratio is 0.64.
PE Ratio65.43
PS Ratio17.63
PB Ratio48.38
Price to Fair Value48.38
Price to FCF1.67K
Price to Operating Cash Flow78.58
PEG Ratio0.64
Income Statement
In the last 12 months, Eli Lilly & Co had revenue of 45.04B and earned 10.59B in profits. Earnings per share was 11.80.
Revenue45.04B
Gross Profit36.62B
Operating Income12.90B
Pretax Income12.68B
Net Income10.59B
EBITDA15.23B
Earnings Per Share (EPS)11.80
Cash Flow
In the last 12 months, operating cash flow was 8.82B and capital expenditures -8.31B, giving a free cash flow of 510.80M billion.
Operating Cash Flow8.82B
Free Cash Flow510.80M
Free Cash Flow per Share0.54
Dividends & Yields
Eli Lilly & Co pays an annual dividend of CHF1.228, resulting in a dividend yield of 0.64%
Dividend Per ShareCHF1.228
Dividend Yield0.64%
Payout Ratio41.52%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.54
52-Week Price Change0.00%
50-Day Moving Average540.00
200-Day Moving Average540.00
Relative Strength Index (RSI)100.00
Average Volume (3m)0.00
Important Dates
Eli Lilly & Co upcoming earnings date is May 1, 2025, TBA Not Confirmed.
Last Earnings DateFeb 6, 2025
Next Earnings DateMay 1, 2025
Ex-Dividend DateFeb 14, 2025
Financial Position
Eli Lilly & Co as a current ratio of 0.12, with Debt / Equity ratio of 234.93%
Current Ratio0.12
Quick Ratio0.12
Debt to Market Cap0.00
Net Debt to EBITDA1.99
Interest Coverage Ratio21.31
Taxes
In the past 12 months, Eli Lilly & Co has paid 2.09B in taxes.
Income Tax2.09B
Effective Tax Rate0.16
Enterprise Valuation
Eli Lilly & Co EV to EBITDA ratio is 47.50, with an EV/FCF ratio of 1.75K.
EV to Sales16.06
EV to EBITDA47.50
EV to Free Cash Flow1.75K
EV to Operating Cash Flow82.02
Balance Sheet
Eli Lilly & Co has $3.42B in cash and marketable securities with $6.68B in debt, giving a net cash position of $30.22B billion.
Cash & Marketable Securities$3.42B
Total Debt$6.68B
Net Cash$30.22B
Net Cash Per Share$31.88
Tangible Book Value Per Share$2.60
Margins
Gross margin is 81.62%, with operating margin of 28.64%, and net profit margin of 23.51%.
Gross Margin81.62%
Operating Margin28.64%
Pretax Margin28.15%
Net Profit Margin23.51%
EBITDA Margin33.81%
EBIT Margin29.88%
Analyst Forecast
The average price target for Eli Lilly & Co is $824.23, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$824.23
Price Target Upside52.63% Upside
Analyst ConsensusStrong Buy
Analyst Count19
Revenue Growth Forecast―
EPS Growth Forecast―